heart positioner

  • 文章类型: Case Reports
    微创心脏手术非体外循环冠状动脉搭桥术(MICSOPCAB)已变得越来越普遍,心脏定位器等设备有助于手术精度。然而,罕见的并发症如心外膜血肿可发生。这里,我们介绍一例75岁接受MICSOPCAB治疗的男性患者,该患者因心脏定位器而出现心外膜血肿.术中通过直接缝合和大毛毡成功修复了血肿。术后恢复顺利,强调警惕监测和及时管理此类并发症的重要性。这种情况强调了在使用心脏定位器期间需要仔细注意,以最大程度地减少不良事件并确保良好的患者预后。
    Minimally invasive cardiac surgery off-pump coronary artery bypass (MICSOPCAB) has become increasingly prevalent, with devices like the heart positioner aiding in surgical precision. However, rare complications such as epicardial hematoma can occur. Here, we present a case of a 75-year-old man undergoing MICSOPCAB who developed an epicardial hematoma due to the heart positioner. The hematoma was successfully repaired intraoperatively with direct suturing and large felts. Postoperative recovery was uneventful, highlighting the importance of vigilant monitoring and prompt management of such complications. This case underscores the need for careful attention during the use of cardiac positioners to minimize adverse events and ensure favorable patient outcomes.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    我们描述了我们第一次使用Triolifter(富士系统,横滨,日本)在心脏手术中。Triolifter更便宜,新型器官固定装置是一种固定压头,主要用于在视频辅助手术下牵引肺部,现已在日本上市。一名被诊断为不稳定型心绞痛的84岁男子在心脏骤停下接受了紧急冠状动脉旁路移植术(CABG)。在主动脉松开和心脏跳动恢复后,观察到左前降支(LAD)吻合部位出血。Triolifter用作心脏定位器,以暴露吻合部位,以在泵上跳动的心脏中止血。也可以通过使用Triolifter牵引右心室前壁来确认后降支(PDA)吻合部位的止血。它可以有效,安全地使用,既没有明显的心外膜下血肿也没有心外膜损伤。在日本,将来,Triolifter可能会用作离泵CABG中的保险设备之一,但是在全球范围内,它也可以毫不犹豫地用于泵上CABG,因为它是如此便宜。
    We describe our first experience with the Triolifter (Fuji Systems, Yokohama, Japan) in cardiac surgery. The Triolifter is a less expensive, novel organ fixation device developed as a fixation indenter mainly for traction of the lung under video-assisted surgery and is now available in Japan. An 84-year-old man diagnosed with unstable angina pectoris underwent emergency coronary artery bypass grafting (CABG) under cardiac arrest. Following the declamping of the aorta and the resumption of the beating heart, bleeding from the left anterior descending artery (LAD) anastomosis site was observed. The Triolifter was used as a heart positioner to expose the anastomosis site for hemostasis in the setting of an on-pump beating heart. Hemostasis of the posterior descending artery (PDA) anastomosis site could also be confirmed by traction of the right ventricular anterior wall using the Triolifter. It could be effectively and safely used with neither significant subepicardial hematoma nor epicardial injury. In Japan, the Triolifter might be used as one of the insurance-covered devices in off-pump CABG in the future, but globally, it could also be used in on-pump CABG without hesitation because it is so inexpensive.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号